Literature DB >> 14657171

Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.

Peter H Larsen1, Jennifer E Wells, William B Stallcup, Ghislain Opdenakker, V Wee Yong.   

Abstract

Remyelination is a critical repair process that is initiated after a demyelinating insult. The failure to remyelinate contributes to neurological diseases such as multiple sclerosis. Here, we test the hypothesis that proteinase activity is required for the extensive remodeling of the extracellular matrix that occurs during remyelination. We show that mice lacking matrix metalloproteinase (MMP)-9 are impaired in myelin reformation after lysolecithin-induced demyelination. This deficiency may be explained at least in part by the failure to clear the accumulation of NG2, an inhibitory proteoglycan that retards the maturation and differentiation of oligodendrocytes that are needed for remyelination. These results emphasize for the first time that upregulation of MMP activity can be important for facilitating regeneration from some types of CNS injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657171      PMCID: PMC6741053     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  83 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 2.  NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.

Authors:  Khalad Karram; Nivedita Chatterjee; Jacqueline Trotter
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

Review 3.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

4.  Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury.

Authors:  Huaqing Liu; Veronica I Shubayev
Journal:  Exp Neurol       Date:  2011-07-02       Impact factor: 5.330

Review 5.  Pathophysiology of the brain extracellular matrix: a new target for remyelination.

Authors:  Lorraine W Lau; Rowena Cua; Michael B Keough; Sarah Haylock-Jacobs; V Wee Yong
Journal:  Nat Rev Neurosci       Date:  2013-08-29       Impact factor: 34.870

6.  Author's reply to: Comment on: Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.

Authors:  Josephine M J Stoffels; Chao Zhao; Wia Baron
Journal:  Cell Mol Life Sci       Date:  2013-08-24       Impact factor: 9.261

7.  Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Authors:  Jung-Yu C Hsu; Lilly Y W Bourguignon; Christen M Adams; Karine Peyrollier; Haoqian Zhang; Thomas Fandel; Christine L Cun; Zena Werb; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

8.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18

9.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

10.  Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord.

Authors:  Junfang Wu; Soonmoon Yoo; Donna Wilcock; Judith M Lytle; Philberta Y Leung; Carol A Colton; Jean R Wrathall
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.